Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer (2024) Heger L, Heidkamp GF, Amon L, Nimmerjahn F, Bäuerle T, Maier A, Erber R, et al. Journal article PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma (2023) Klümper N, Wüst L, Saal J, Ralser DJ, Zarbl R, Jarczyk J, Breyer J, et al. Journal article T cell-mediated elimination of cancer cells by blocking CEACAM6–CEACAM1 interaction (2022) Pinkert J, Boehm HH, Trautwein M, Doecke WD, Wessel F, Ge Y, Gutierrez EM, et al. Journal article Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA) (2022) Hassel JC, Schank TE, Smetak H, Muhlbauer J, Salzmann M, Machiraju D, Menzer C, et al. Journal article Integrative evaluation of primary and metastatic lesion spectrum to guide anti-PD-L1 therapy of non-small cell lung cancer: results from two randomized studies (2021) Ma SC, Tang XR, Long LL, Bai X, Zhou J, Duan ZJ, Wang J, et al. Journal article Gas plasma irradiation of breast cancers promotes immunogenicity, tumor reduction, and an abscopal effect in vivo (2021) Mahdikia H, Saadati F, Freund E, Gaipl U, Majidzadeh-a K, Shokri B, Bekeschus S Journal article Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy (2020) Daillere R, Derosa L, Bonvalet M, Segata N, Routy B, Gariboldi M, Budinska E, et al. Journal article, Review article Regulatory T cells and cytotoxic T cells close to the epithelial–stromal interface are associated with a favorable prognosis (2020) Rudolf J, Büttner-Herold M, Erlenbach-Wuensch K, Posselt R, Jeßberger J, Haderlein M, Hecht M, et al. Journal article Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer (2019) Safi S, Yamauchi Y, Stamova S, Rathinasamy A, Op Den Winkel J, Juenger S, Bucur M, et al. Journal article Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines (2019) Bek S, Stritzke F, Wintges A, Nedelko T, Boehmer DFR, Fischer JC, Haas T, et al. Journal article